Testing effectiveness (Phase 2)Ended earlyNCT02566603
What this trial is testing
PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITP
Who this might be right for
Immune Thrombocytopenia
Protalex, Inc. 15
Showing 20 of 177 results